At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
enteral feeding with Oxepa® and Glutasolve®dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Interventions to Increase Organ Procurement Nutritional Status and Enteral Absorption Capability After Brain Death (R38OT10585)
The University of Texas Health Science Center, Houston·interventional·Posted Mar 9, 2009·Updated Jun 26, 2014
In Brief
A clinical study evaluating enteral feeding with Oxepa® and Glutasolve® for Brain Death. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The investigators propose to assess 36 donors' nutritional status using accepted parameters (prealbumin, resting energy expenditure); to assess nutrient intestinal absorption through 13Curacil breath tests; and to evaluate serum concentrations of IL-6 and TNFalpha to determine if continuing or initiating enteral feeding and nutritional supplementation is effective in restoring or maintaining nutritional parameters.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Death
CountriesUnited States
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMar 2009
Primary CompletionAug 2012
Study CompletionDec 2013
TodayJul 2026
First PostedMar 9, 2009
Enrollment StartFeb 1, 2009
Primary CompletionAug 1, 2012
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 17.3 years ago
Interventions
enteral feeding with Oxepa® and Glutasolve®dietary
enteral feeding with Oxepa® and RESOURCE® GLUTASOLVE®